Clinical Development Licensing Pharmacy 
Worldwide Clinical Trials
FEBRUARY 21, 2024
During clinical development, new chemical entities (NCEs) require an absorption, metabolism, and excretion (AME) study. Dosing Our pharmacy services can prepare liquid, solid, and intravenous dosage formulations. To accomplish this, we pay careful attention to both dosing and sample collection.
XTalks
MARCH 17, 2025
Roche, a global leader in biotechnology and diagnostics, has entered into an exclusive collaboration and licensing agreement with Zealand Pharma, a specialist in innovative therapeutics, to co-develop and co-commercialize petrelintide as a potential foundational therapy for people with overweight and obesity. billion $1.4
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MARCH 1, 2023
Orvacabtagene autoleucel is under clinical development by Bristol-Myers Squibb and currently in Phase II for Relapsed Multiple Myeloma. The company offers its products across the world to wholesalers, retail pharmacies, hospitals, medical professionals and government entities.
Pharmaceutical Technology
JANUARY 2, 2023
Danicamtiv is under clinical development by Bristol-Myers Squibb and currently in the Phase I and Phase II in clinical pathway. The company offers its products across the world to wholesalers, retail pharmacies, hospitals, medical professionals and government entities.
XTalks
APRIL 24, 2023
For rare disease studies where there is little or no clinical trial experience, outcome assessments would have to be validated within a clinical development program. This is important since not all pharmacies and sites are eligible to prepare and administer gene therapy due to biosafety and technical reasons.
XTalks
NOVEMBER 28, 2023
Ilsun Hong VP and Product Evaluation Team Leader, Samsung Bioepis To have a biologic product ready for launch, it takes years of commitment from planning, early-stage development, clinical development, regulatory approval to supply readiness.
The Pharma Data
JANUARY 24, 2021
Sairiyo is a biotechnology company focused on repurposing and developing improved formulations of naturally derived compounds for serious, rare, and life-threatening diseases with the aim to obtain European Medicines Evaluation Agency and U.S. Food and Drug Administration (“FDA”) approval.
Expert insights. Personalized for you.
200 
Let's personalize your content